Font size
WorksheetsMalaria - Treatment and Management
Total questions: 27
Worksheet time: 14mins
Classification of anti-malarial drugs
- Prevent establishment of the parasite in the liver
Causal prophylactic drugs
Blood schizonticidal drugs
Tissue schizonticides:
Gametocytocidal drugs
Classification of anti-malarial drugs
- Attack the parasite in the RBC, preventing/ terminating the clinical attack
Causal prophylactic drugs
Blood schizonticidal drugs
Tissue schizonticides
Gametocytocidal drugs
Classification of of anti-malarial drugs
- Act on pre-erythrocytic forms in the liver
Causal prophylactic drugs
Blood schizonticidal drugs
Tissue schizonticides
Gametocytocidal drugs
Classification of anti-malarial drugs
- Destroy the sexual forms of the parasite in the blood
Tissue schizonticides
Gametocytocidal drugs
Hypnozoitocidal or anti-relapse drugs
Sporonticidal drugs
Classification of anti-malarial drugs
- Kill the dormant forms in the liver
Tissue schizonticides
Gametocytocidal drugs
Hypnozoitocidal or anti-relapse drugs
Sporonticidal drugs
Classification of anti-malarial drugs
- Inhibit the development of oocysts on the gut wall of the mosquito which has fed on the gametocyte carrier so that the mosquito cannot transmit the infection
Tissue schizonticides
Gametocytocidal drugs
Hypnozoitocidal or anti-relapse drugs
Sporonticidal drugs
Use of antimalarial drugs
- Used before infection occurs or becomes evident
- Example: a blood schizonticidal drug may have minimal effects on parasite growing on liver, but if it is still present in the blood when the merozoites leave the liver and invade the blood cells for the first time, it will effectively prevent symptomatic malaria
Protective/Prophylactic
Curative
Preventive
Use of antimalarial drugs
- Action on the established infection
- Example: use of blood schizonticidal drug for the treatment of the acute attack and in the case of relapsing malaria, radical treatment of the dormant liver forms
Protective/Prophylactic
Curative
Preventive
Use of antimalarial drugs
- Deterrence of infection of mosquitos with the use of gametocytocidal drugs to attack the gametocytes in the blood of the human host
- Interruption of the development of the sporogenic phase in the mosquito when it feeds on the blood of an infected person who has been given the appropriate sporonticidal compound
Protective/Prophylactic
Curative
Preventive
Defined as the absence of parasitemia on Day 14 (Day 28 for low to moderate transmission areas) irrespective of axillary temperature without previously meeting any criteria of EFT, late clinical failure, or late parasitological failure
Appropriate Clinical Response (ACR)
Accurate Clinical Response (ACR)
Adequate Clinical Response (ACR)
Efficient Clinical Response (ECR)
Common antimalarial drugs
- Drug of choice
Quinine
Artemotil
Primaquine
Chloroquine
Common antimalarial drugs
- DOC for pregnancy
Quinine
Artemotil
Primaquine
Chloroquine
Common antimalarial drugs
- DOC for severe malaria (3)
Artesunate injection
Chloroquine
Quinine
Artemether
Artemotil
Common antimalarial drugs
- Therapy for severe malaria
Chloroquine & Quinine
Artemotil & Qinghaosu
Artemisinin & Qinghaosu
Artemotil & Quinine
Common antimalarial drugs
- Newly registered against severe malaria
Artemotil
Quinine
Artemisinin
Qinghaosu
Common antimalarial drugs
- Chloroquine-resistant vivax malaria
Quinine-based compounds and a partner drug w/ long half-life
Artemisinin-based compounds and a partner drug w/ short half-life
Quinine-based compounds and a partner drug w/ short half-life
Artemisinin-based compounds and a partner drug w/ long half-life
Common antimalarial drugs
- DOC for gametocytes & hypnozoites
Chloroquine
Primaquine
Quinine
Artemisinin
Common antimalarial drugs
- Most common drug combination used in uncomplicated falciparum malaria
Artemisinin & Qinghaosu
Artemisinin & Lumefantrine
Artemether & Lumefantrine
Artemether & Qinghaosu
Drug resistance
- Mildest form of resistance
- Characterized by initial clearance of parasites but recrudescence occurs within a month after the start of treatment
RI
RII
RIII
Multidrug-resistance
Drug resistance
- Initial reduction in parasitemia after treatment
- Failure to clear the blood of asexual parasites and soon after an increase of parasitemia follows
RI
RII
RIII
Multidrug-resistance
Drug resistance
- Severe form of resistance in which parasitemia will either show no significant change with treatment or will eventually increase
RI
RII
RIII
Multidrug-resistance
Drug resistance
- Considered when treatment failure occurs with 3 or more antimalarial agents
- Artesunate + mefloquine: first line regimen
RI
RII
RIII
Multidrug-resistance
Other treatment
- Given in cases of renal failure in severe malaria
Dopamine
Heparin
Corticosteroids
Low molecular weight dextran
Other treatment
- For control of seizures
Dopamine
Diazepam
Phenytoin
Corticosteroids
Other treatment
- Given in cases of status epilepticus
Dopamine
Diazepam
Phenytoin
Corticosteroids
Malaria prophylaxis be should taken with good compliance for the duration of the stay and should be continued for ________ after the last possible exposure to infection (parasites may still emerge from liver).
4 weeks
4 hours
4 days
4 months
Prophylactic drugs for malaria
Chloroquine
Mefloquine
Doxycycline
Atovaquone/Proguanil
Primaquine
